Integrating treatments for opioid use disorders into medical care: the role of buprenorphine and naltrexone

Dr. Todd Korthuis, M.D., M.P.H.
Associate Professor of Medicine, Oregon Health & Science University

Click here to RSVP.
Event is free, lunch provided.


Event Details

Days
Hours
Minutes
Seconds
Start Date
End Date
Event Category
Scroll to Top

The British Columbia Centre for Excellence in HIV/AIDS Laboratory has discontinued gp-41 resistance testing as T-20 (enfuvirtide/Fuzeon) is no longer available in Canada as of March 31, 2025